Notice Concerning Safety or Efficacy Issues. Each Party shall provide the other Party with notice, within one (1) business day after notification or other information (directly or indirectly) that it receives (and providing, as soon as reasonably possible, copies of any associated written requests) that (a) raises any material concerns regarding the safety or efficacy of Licensed Product, (b) indicates or suggests a Third Party claim arising in connection with Licensed Product, or (c) is reasonably likely to lead to a recall of Licensed Product. Information that shall be disclosed (to the extent it relates to the subject matter of the foregoing clauses (a) through (c), inclusive) shall include without limitation:
Appears in 3 contracts
Samples: Development and License Agreement, Development and License Agreement, Collaboration, Development and License Agreement (Zosano Pharma Corp)
Notice Concerning Safety or Efficacy Issues. Each Party shall provide the other Party with notice, within one (1) business day after notification or other information (directly or indirectly) that it receives (and providing, as soon as reasonably possible, copies of any associated written requests) that (a) raises any material concerns regarding the safety or efficacy of any Licensed Product, (b) indicates or suggests a Third Party claim arising in connection with any Licensed Product, or (c) is reasonably likely to lead to a recall of any Licensed Product. Information that shall be disclosed (to the extent it relates to the subject matter of the foregoing clauses (a) through (c), inclusive) shall include include, without limitation:
Appears in 2 contracts
Samples: Collaboration, Development and License Agreement (Zosano Pharma Corp), Collaboration, Development and License Agreement (Zosano Pharma Corp)
